✦ LIBER ✦

The oral combination of thalidomide, cyclophosphamide and dexamethasone (ThaCyDex) is effective in relapsed/refractory multiple myeloma

✍ Scribed by García-Sanz, R; González-Porras, J R; Hernández, J M; Polo-Zarzuela, M; Sureda, A; Barrenetxea, C; Palomera, L; López, R; Grande-García, C; Alegre, A

Book ID: 110055848
Publisher: Nature Publishing Group
Year: 2004
Tongue: English
Weight: 169 KB
Volume: 18
Category: Article
ISSN: 0887-6924
DOI: 10.1038/sj.leu.2403322

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Low-dose thalidomide in combination with

Low-dose thalidomide in combination with oral weekly cyclophosphamide and pulsed dexamethasone is a well tolerated and effective regimen in patients with relapsed and refractory multiple myeloma

✍ Charalampia Kyriakou; Kirsty Thomson; Shirley D'Sa; Angela Flory; Judith Hanslip 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB

Clarithromycin with low dose dexamethaso

Clarithromycin with low dose dexamethasone and thalidomide is effective therapy in relapsed/refractory myeloma

✍ T. C. M. Morris; P. J. Kettle; M. Drake; F. C. G. Jones; D. R. Hull; K. Boyd; A. 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

VTD combination therapy with bortezomib–

VTD combination therapy with bortezomib–thalidomide–dexamethasone is highly effective in advanced and refractory multiple myeloma

✍ Pineda-Roman, M; Zangari, M; van Rhee, F; Anaissie, E; Szymonifka, J; Hoering, A 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 279 KB

Bortezomib in combination with intermedi

Bortezomib in combination with intermediate-dose dexamethasone and continuous low-dose oral cyclophosphamide for relapsed multiple myeloma

✍ Martin Kropff; Guido Bisping; Elke Schuck; Peter Liebisch; Nicola Lang; Markus H 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 549 KB

Lenalidomide (Revlimid) combined with co

Lenalidomide (Revlimid) combined with continuous oral cyclophosphamide (endoxan) and prednisone (REP) is effective in lenalidomide/dexamethasone-refractory myeloma

✍ Niels W.C.J. Van De Donk; Shulamit Wittebol; Monique C. Minnema; Henk M. Lokhors 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

The combination of bortezomib, melphalan

The combination of bortezomib, melphalan, dexamethasone and intermittent thalidomide is an effective regimen for relapsed/refractory myeloma and is associated with improvement of abnormal bone metabolism and angiogenesis

✍ Heath, D; Terpos, E; Kastritis, E; Roussou, M; Christoulas, D; Anagnostopoulos, 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 177 KB